We are looking to collaborate with academic researchers and institutional research centres working on novel, innovative drug delivery systems and drug development platforms across a range of advanced modalities. This includes, but is not limited to, peptides, oligonucleotides and antibodies.

We are particularly interested in the following drug delivery approaches:

• Technologies that facilitate oral delivery of macromolecules
• Approaches for elongating dosing intervals, e.g. long-acting delivery systems for peptides and oligonucleotides that can enable monthly or biannual dosing
• Technologies or compounds that offer patient-centric approaches to drug delivery and/or offer attractive alternatives to injectables, e.g. macromolecule transdermal delivery
• Approaches for targeted delivery of large nucleic acids ready for clinical translation

By collaborating with us, you gain access to advanced research tools including analogues of key modalities and nanomedicines to serve as a benchmark for technology or reference to test the hypotheses. We also provide expertise through our scientists with input to study designs, critical quality attributes and clinical translation of novel technologies. Where appropriate, we also have the potential to facilitate access to in vivo resources and/or in vitro assays for validation. We do not provide funding to support this work, but we will provide a letter of support for you to include in your grant funding application.

This programme is open to basic and applied researchers working in academic settings across all geographies.